High content screening

Statistics has shown that every year over 10 million cases of cancer are diagnosed all over the world. For this reason, scientists, researchers and doctors are constantly elaborating new solutions for this malady of the century.

Fluofarma is a privately-held contract service provider which offers High Content Screening (HCS) services for anticancer drugs discovery and predictive toxicity testing. Our pioneering research work in this field is based on an accurate and fastidious process.

In fact, once our experienced scientists agree upon a target, they initiate a primary and secondary screening which is characterized by its high thought put in living cells and by its flexible services. The result is lead optimization including functional identification and specific expertise.

We are relentlessly trying to develop and improve our oncology researches in order to provide our customers reliable and efficient anticancer drugs discoveries backed up with competent and trustworthy services.

For more informations on our High content screening

If you need to have further details on our High content screening, do not hesitate to contact-us. It is a pleasure to answer your demands.